3912 Taubman Center

Ann Arbor, Michigan 48109-0362

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Hepatocellular, Hepato Cellular Carcinoma (HCC), Liver Cancer

Studies at this site

• Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment — Completed
• First Line Hepato Cellular Carcinoma (HCC) — Completed
• Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate — Completed